Veru to present at the jefferies virtual healthcare conference

Miami, may 25, 2021 (globe newswire) -- veru inc. (nasdaq: veru), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate and breast cancer, today announced that the company will present at the jefferies virtual healthcare conference. the presentation will be available through the conference on tuesday, june 1st at 8:00 a.m. et.
VERU Ratings Summary
VERU Quant Ranking